New orally available drug for spinal cord injury found to be safe and tolerable in healthy participants.
Comprehensive cost and utilization of commercial CAR-T therapy in pediatric B-ALL patients
A new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, “The price of hope: CAR-T therapy in pediatric leukemia.”